2007 Compounding Pharmacies Labelling 
The Thyroid Pharmacist
JUNE 30, 2023
Dr. Bernard Bihari is credited with making these discoveries about using naltrexone off-label, at lower doses. The first article was published in 2007, and it showed LDN as an effective and safe therapy for Crohn’s disease. [4] It’s also best to work with a compounding pharmacy that can help you titrate your dose correctly.
The Thyroid Pharmacist
NOVEMBER 15, 2024
Ozempic is a GLP-1 agonist and is actually marketed as a diabetes drug, but many physicians are prescribing it for weight loss (off label-use). Ozempic’s label warns, “In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. 2007 Mar;2(2):366-73. Diabetes Care.
Expert insights. Personalized for you.
Let's personalize your content